Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexesMarcus Bantscheff, Gerard Drewes, Carsten Hopf et al.|Nature Biotechnology|2011Cited by 666
Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory DisordersDavid Harrison, Alan P. Watt, Jane Scanlon et al.|Journal of Medicinal Chemistry|2023Cited by 62
Reversal of High Fat Diet-Induced Obesity, Systemic Inflammation, and Astrogliosis by the NLRP3 Inflammasome Inhibitors NT-0249 and NT-0796Peter Thornton, Alan P. Watt, Valérie Reader et al.|Journal of Pharmacology and Experimental Therapeutics|2024Cited by 51
Profile of NT-0527, a brain penetrant NLRP3 Inflammasome inhibitor suitable as an <i>in vivo</i> tool compound for neuroinflammatory disordersDavid Harrison, Alan P. Watt, Andy Billinton et al.|RSC Medicinal Chemistry|2025Cited by 3